MX9606031A - Inhibidores de cetona perfluoroalquilica de elastasa y procesos para fabricarlos. - Google Patents

Inhibidores de cetona perfluoroalquilica de elastasa y procesos para fabricarlos.

Info

Publication number
MX9606031A
MX9606031A MX9606031A MX9606031A MX9606031A MX 9606031 A MX9606031 A MX 9606031A MX 9606031 A MX9606031 A MX 9606031A MX 9606031 A MX9606031 A MX 9606031A MX 9606031 A MX9606031 A MX 9606031A
Authority
MX
Mexico
Prior art keywords
elastase
processes
manufacture
inhibitors
ketone inhibitors
Prior art date
Application number
MX9606031A
Other languages
English (en)
Other versions
MXPA96006031A (es
Inventor
William A Metz
Timothy T Curran
Joseph P Burkhart
Michael R Angelastro
Norton P Peet
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of MX9606031A publication Critical patent/MX9606031A/es
Publication of MXPA96006031A publication Critical patent/MXPA96006031A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta invencion se refiere a compuestos que son inhibidores de elastasa, particularmente elastasa de neutrofilos humanos, y a procesos novedosos para fabricarlos. Como inhibidores de elastasa de neutrofilos humanos, los compuestos son utiles en el tratamiento de un paciente afligido con una enfermedad inflamatoria asociada con neutrofilos.
MXPA/A/1996/006031A 1994-06-02 1996-12-02 Inhibidores de cetona perfluoroalquilica de elastasa y procesos para fabricarlos MXPA96006031A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US25285794A 1994-06-02 1994-06-02
US252857 1994-06-02
US32752094A 1994-10-20 1994-10-20
US327520 1994-10-20
PCT/US1995/005363 WO1995033762A1 (en) 1994-06-02 1995-05-01 Perfluoroalkyl ketone inhibitors of elastase and processes for making the same

Publications (2)

Publication Number Publication Date
MX9606031A true MX9606031A (es) 1998-05-31
MXPA96006031A MXPA96006031A (es) 1998-10-23

Family

ID=

Also Published As

Publication number Publication date
NO965098D0 (no) 1996-11-29
DE69513167D1 (de) 1999-12-09
ATE186305T1 (de) 1999-11-15
CN1152048C (zh) 2004-06-02
FI964789A0 (fi) 1996-11-29
FI964789L (fi) 1996-11-29
CA2189526A1 (en) 1995-12-14
HUT75318A (en) 1997-05-28
EP0763055A1 (en) 1997-03-19
JP3721538B2 (ja) 2005-11-30
HU9603311D0 (en) 1997-01-28
WO1995033762A1 (en) 1995-12-14
NZ284766A (en) 1998-06-26
NO316706B1 (no) 2004-04-13
KR100366328B1 (ko) 2003-03-06
CN1149876A (zh) 1997-05-14
JPH10501529A (ja) 1998-02-10
EP0763055B1 (en) 1999-11-03
ES2137509T3 (es) 1999-12-16
GR3032294T3 (en) 2000-04-27
DE69513167T2 (de) 2000-06-15
AU2400095A (en) 1996-01-04
IL113941A0 (en) 1995-08-31
HU221311B1 (en) 2002-09-28
FI964789A7 (fi) 1996-11-29
AU690986B2 (en) 1998-05-07
TW376388B (en) 1999-12-11
NO965098L (no) 1997-01-31
IL113941A (en) 2000-02-17
CA2189526C (en) 2001-02-27
US6008196A (en) 1999-12-28
DK0763055T3 (da) 2000-05-08

Similar Documents

Publication Publication Date Title
CA2189526A1 (en) Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
ATE355293T1 (de) Substituierte 7-aza-(2.2.1)bicycloheptane für die behandlung von krankheiten
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
DOP2002000429A (es) Imidazotriazinas
BR9910671A (pt) 24-hidroxivitamina d, análogos e utilizações dos mesmos
ATE439844T1 (de) Kombinationen für die behandlung entzündlicher erkrankungen
ES2124461T3 (es) Derivados de oxalilamino-benzofurano y de benzotienilo.
ATE542801T1 (de) Zur behandlung von neoplastischen krankheiten, entzündlichen erkrankungen und erkrankungen des immunsystems geeignete 2,4-pyrimidindiamine
ES2192839T3 (es) Timosina beta 4 oxidada.
ECSP105739A (es) Anticuerpos de neutralización contra gdf-8
TR200102817T2 (tr) Antiinflamatuar ajanlar olarak faydalı bileşikler
BRPI0407662A (pt) derivados do ácido 1-fenilalcanocarboxìlico para o tratamento de doenças neurodegenerativas
ATE448232T1 (de) Substituierte heterozyklen
DE69635205D1 (de) Extrakorporaler blutkreislauf für die heilung entzündlicher krankheiten
ATE271861T1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
PT804465E (pt) Novos inibidores da elastase
EP1126850A4 (en) TREATMENT OF RETINAL DISEASES
TR200200278T2 (tr) Kalsilitik bileşimler
MX9403032A (es) Quinolil-dihidropiridinas condensadas, procedimiento para su fabricacion ysu uso en medicamentos.
UY27312A1 (es) Nuevos heterociclos 3
DK1596879T3 (da) Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis
ES2140544T3 (es) Utilizacion de efaroxan y de sus derivados para la fabricacion de medicamentos destinados al tratamiento de las enfermedades neurodegenerativas.
FI972673A7 (fi) 4,4-(disubstituoitu)sykloheksan-1-oli-monomeereja ja vastaavia yhdiste itä
DE502004007517D1 (de) Anti-apoptotisch wirksame apatamere
FR2786099B1 (fr) Nouvelle application therapeutique de la 1,6-dimethyl-8beta- hydroxymethyl-10alpha-methoxyergoline